Study of Glaucoma Treatment With Food Additives

Future Products Management

Status and phase

Terminated

Phase 2

Phase 1

Conditions

Glaucomatous Neuropathy

Treatments

Drug: Vitamins, minerals and medical herbs

Study type

Interventional

Funder types

Other

Identifiers

NCT00196677

g88

Details and patient eligibility

About

The purpose of this study is to determine if certain food additives are effective in the treatment of glaucoma, improving and reversing the progress of the disease.

Full description

Glaucomatous neuropathy is a condition that worsens with time causing atrophy of the optic nerve and narrowing of the visual field which may culminate in blindness. The treatment tested in the trial employs certain food additives intended to reverse this pathology.

Enrollment

25 estimated patients

Sex

All

Ages

40 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Stable open angle glaucoma - with equilibrated eye internal pressure
Above the age of 50 years and have severe damage that does not progress to the vision field in the upper and lower half. Scoring of the vision field will be made according to the Agis study instructions.

Exclusion criteria

Eye diseases excluding past cataract operation
Allergy to one of the components in the preparation
Deterioration in the vision field in the last year
Kidney diseases, gastrointestinal (G.I.) tract, liver diseases, coagulation problems and thyroid diseases
Persons who take steroids
Diabetics or unbalanced hyperglycemia
Autoimmune diseases
Hypertension (not responding to treatment)
Psychiatric treatment with drugs, psychiatric pathologies
Pregnancy
Ability to take more than 3 pills per day regularly
Smoking